P harmacists must sometimes feel like they have one foot on the boat and one on the dock. As the dock rope loosens, it's hard to keep a foot in both places. Do you stay on the dock or hop on the boat?
Try substituting the following terms:
The boat: Automated dispensing technology and premixed or outsource-prepared intravenous admixtures
The dock: Unit-dose drug dispensing and IV admixture programs On October 6, 1995, I participated in an interprofessional panel whose goal was to determine and recommend the highest-priority activities for preventing adverse drug events in hospitals. Among the seven recommendations made by this interdisciplinary group was, "Hospitals should use unit-dose medication distribution and pharmacy-based IV admixture programs" because "the superior safety of these systems has been firmly established by documented research." 1 If pharmacists are to practice at the evidence-based level, shouldn't we aspire to institute and maintain these safe drug-distribution systems?
Several years earlier, however, I participated in a similar forum, sponsored by the American Society of Health-System Pharmacists (ASHP). The purpose of this endeavor was to address the pub-lic's concern, and anwer questions from the Food and Drug Administration (FDA), about the quality of sterile products produced by pharmacists. Cases of deaths and harm resulting from improperly prepared parenteral and ophthalmic products had resulted in an erosion of public confidence in pharmacists and thus the attention from the FDA. Rather than protecting the public from adverse drug events, pharmacists were actually contributing to them. The result of this forum was the ASHP Technical Assistance Bulletin on Quality Assurance for Pharmacy-Prepared Sterile Products. 2 Obviously, the "superior safety" of the pharmacy-based IV admixture system was not safe enough.
The current wave of interest in process improvement and medication safety creates tremendous opportunity for pharmacists. While it is currently in vogue to talk about not blaming people and finding "systems solutions" for medicationuse problems, we cannot forget the important role that humans, particularly pharmacists, have in improving medication use safety.
First, there is the issue of "human error." As noted in my article in this issue, "A Review of the Safety of Intravenous Drug-Delivery Systems," (p. 1047), pharmacybased IV admixture programs were developed as a result of errors that occured in systems that involved only physicians and nurses. It is also noted that complacency among pharmacists makes pharmacy-based IV admixture systems less safe than they could be. 3 My guess is that the same issues of human error apply to unit-dose drug distribution systems as well. The next generation of systems will rely less on human actions that are known to be error-prone and more on technology that is less likely to cause errors.
Another important issue is the role of humans in a technologybased system. Some pharmacists fear that they will lose their jobs as machines carry out the tasks they now perform. The contemporary role of pharmacists, however, is in measuring, monitoring, and improving the medication use process, not in performing menial, error-prone tasks. Logical roles for pharmacists include assessment of the new technology to ensure that it is used properly and that it in fact improves the drug use process enough to justify the inevitably increased costs.
For example, does automated, point-of-care dispensing technology improve patient safety to the extent that it justifies the cost? Certainly, "wrong time" errors are likely to decrease because of the proximal location of medications to patients. On the other hand, if not properly configured, the number of "wrong patient," "wrong drug," and "wrong dose" errors may actually increase because a double-check by a phar-Editorial macist is bypassed. If the dispensing unit is not properly stocked, a single error may result in many adverse drug events if the wrong medication is placed in the device and administered to several patients. There is an important human aspect, here, in making sure that new technology is safely applied, and this should be the pharmacist's focus (not worrying about the jobs that machines will eliminate).
We need to start evaluating the safety of new technologies compared with the systems they replace, and ensure that the changes made in the medication use process take us closer to a "failsafe" system. Our current systems are safer than the ones that they replaced, but they are not as safe as they need to be.
Get on the boat, but remember why you were on the dock. 
